These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 21564075

  • 1. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
    Bergrem A, Dahm AE, Jacobsen AF, Mowinckel MC, Sandvik L, Sandset PM.
    Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075
    [Abstract] [Full Text] [Related]

  • 2. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V, Marino R, Scaraggi FA, Di Bari L, Giannoccaro F, Petronelli M, Ranieri P, Tannoia N, Schiraldi O.
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [Abstract] [Full Text] [Related]

  • 3. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC, Guasch JF, Kamphuisen PW, Vos HL, Rosendaal FR, Bertina RM.
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [Abstract] [Full Text] [Related]

  • 4. Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study.
    Bergrem A, Dahm AE, Jacobsen AF, Sandvik L, Sandset PM.
    Thromb Haemost; 2012 Dec; 108(6):1165-71. PubMed ID: 23015030
    [Abstract] [Full Text] [Related]

  • 5. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J, Thomassen MC, Rimmer J, Hamulyak K, van der Meer J, Tans G, Preston FE, Rosing J.
    Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
    [Abstract] [Full Text] [Related]

  • 6. Resistance to activated protein C in women using oral contraceptives.
    Spannagl M, Dick A, Assmann A, Heinemann L, Schramm W.
    Semin Thromb Hemost; 1998 Jul; 24(5):423-30. PubMed ID: 9834008
    [Abstract] [Full Text] [Related]

  • 7. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Koster T, Bertina RM, Vandenbroucke JP.
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
    Kostka H, Schwarz T, Schellong S, Mix C, Kuhlisch E, Temelkova-Kurktschiev T, Henkel E, Köhler C, Gehrisch S, Siegert G.
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
    Magdelaine A, Soubrier F, Berkane N, Uzan S, Verdy E.
    Ann Biol Clin (Paris); 1998 Jan; 56(4):445-50. PubMed ID: 9754280
    [Abstract] [Full Text] [Related]

  • 14. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
    Graf LL, Welsh CH, Qamar Z, Marlar RA.
    Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I, De Stefano V, Taioli E, Paciaroni K, Rossi E, Mannucci PM.
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [Abstract] [Full Text] [Related]

  • 18. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
    Castaman G, Tosetto A, Simioni M, Ruggeri M, Madeo D, Rodeghiero F.
    Thromb Haemost; 2001 Sep; 86(3):804-8. PubMed ID: 11583311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.